Detalhe da pesquisa
1.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis;
78(3): 746-755, 2024 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37972288
2.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis;
78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37633258
3.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis;
228(2): 185-195, 2023 07 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36683410
4.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis;
227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36415904
5.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis;
2023 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38041853
6.
Racial Differences in the Diagnosis of Lyme Disease in Children.
Clin Infect Dis;
76(6): 1129-1131, 2023 03 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36314085
7.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis;
76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36611252
8.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep;
72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37227984
9.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36921274
10.
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and SARS-CoV-2-Related Hospitalizations: A Statewide Report From the Minnesota Electronic Health Record Consortium.
Clin Infect Dis;
75(5): 890-892, 2022 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35137021
11.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36580430
12.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep;
71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36264840
13.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(4): 139-145, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35085224
14.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep;
71(13): 495-502, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35358170
15.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(7): 255-263, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35176007
16.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35239634
17.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep;
71(29): 931-939, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35862287
18.
A Clinical Prediction Rule for Bacterial Musculoskeletal Infections in Children with Monoarthritis in Lyme Endemic Regions.
Ann Emerg Med;
80(3): 225-234, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35643775
19.
Novel Uses of Traditional Algorithms for Septic Arthritis.
J Pediatr Orthop;
42(2): e212-e217, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34995263
20.
Validation of Septic Knee Monoarthritis Prediction Rule in a Lyme Disease Endemic Area.
Pediatr Emerg Care;
38(2): e881-e885, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34160185